Members

  First name: Bruno
  Last name: Fantin
  Function: Professor of internal medicine
  Position: Head of Medicine
  Email: bruno.fantin
._
_.
inserm.fr

Research interest


Our research project relies on the study of the relationship between antibiotics and bacterial resistance with a double aspect. On one hand, we investigate the impact of antibiotic exposure on the selection of antibiotic resistance among bacteria within foci of infection but most of all among commensal flora ; on the other hand we investigate the impact of a specific mechanism of resistance on the in vivo activity of antiibotics in bacterial foci of infection in terms of bactericidal activity of the antibiotics, selection of resistant mutants and in terms of fitness of resistant strains as compared with susceptible parental strains. The strength of our activity is to have set up a double approach allowing us to investigate this public health issue : on one hand, prospective clinical investigations allowing the study of the impact of antibiotic treatment in various populations : healthy volunteers, outpatients at admission, inpatients ; on the other hand, our recognized expertise on experimental models of animal infections and  pharmacokinetic/pharmacodynamic (PK/PD) approach allowed us to study the in vivo impact of a mechanims of resistance clinically relevant on  antibiotics activity and fitness of resistant bacterial strains.

Education

Degree

Hospital
– 1981: Intern (Assistance Publique-Hôpitaux de Paris)
– 1989: Assistant Professor (Assistance Publique-Hôpitaux de Paris)
– 1997: Head of the Unit of Internal Medicine, Beaujon Hospital (Assistance Publique-Hôpitaux de Paris)
– 2000: Head of the Department of Internal Medicine, Beaujon Hospital (Assistance Publique-Hôpitaux de Paris)

University
– 1986: M. D. Faculty of Medicine Xavier-Bichat, University Paris 7.
– 1992: Ph. D. in Clinical and Experimental Pharmacology, University Paris 7.
– 1995: Research directorship, University Paris 7.
– 1996: Professor, Internal Medicine, University Paris 7.

Academic positions

– 1986: M. D. Faculty of Medicine Xavier-Bichat, University Paris 7.
– 1992: Ph. D. in Clinical and Experimental Pharmacology, University Paris 7.
– 1995: Research directorship, University Paris 7.
– 1996: Professor, Internal Medicine, University Paris 7.

Research training (post doctoral)

– 1985-1986 : Student, INSERM U 13, Professor Pocidalo, Paris.
– 1987-1988: Research Fellow, Professor Craig Laboratory, University of Wisconsin, Madison, USA.
– 1992-1994: Research Fellow, INSERM U 13, Professor Carbon, Paris.
– 1994-2000: Responsible for a research group, INSERM, EMI9933.
– 2001-2002: Director, INSERM EMI 9933.
– 2005-2013 : Director, EA3964, University Paris 7.

List of the main publications

Alexandre K, Chau F, Guérin F, Massias L, Lefort A, Cattoir V, Fantin B
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2016

de Lastours V, Chopin D, Jacquier H, d'Humieres C, Burdet C, Chau F, Denamur E, Fantin B
Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals.
Antimicrob Agents Chemother 2016, 60, 6941-6944.

Galy A, Lepeule R, Goulenok T, Buzele R, de Lastours V, Fantin B
Presentation and impact of catheter-associated thrombosis in patients with infected long-term central venous catheters: a prospective bicentric observational study.
Annals of Medicine 2016, 48, 182-189.

Lefort A, Chau F, Lepeule R, Dubée V, Kitzis MD, Dion S, Fantin B
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.
International Journal of Antimicrobial Agents 2014, 43, 366-369.

de Lastours V, Bleibtreu A, Chau F, Burdet C, Duval X, Denamur E, Fantin B
Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle.
The Journal of Antimicrobial Chemotherapy 2014, 69, 761-768.

de Lastours V, Chau F, Roy C, Larroque B, Fantin B
Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
The Journal of Antimicrobial Chemotherapy 2014

Guillard T, Cambau E, Chau F, Massias L, de Champs C, Fantin B
Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
Antimicrobial Agents and Chemotherapy 2013, 57, 5830-5835.

Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2013, 31, 2493-2499.

Dubée V, Lenoir T, Leflon-Guibout V, Briere-Bellier C, Guigui P, Fantin B
Three-month antibiotic therapy for early-onset postoperative spinal implant infections.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1481-1487.

de Lastours V, Cambau E, Guillard T, Marcade G, Chau F, Fantin B
Diversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacin..
The Journal of infectious diseases 2012, 206, 1399-1406.


Exhaustive list of publications

2023


Oliosi E, Rossi G, Nguyen Y, Honsel V, Bert F, Roux O, Fantin B, Lefort A
Enterococcal pyogenic liver abscesses: high risk of treatment failure and mortality.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2023, 42, 193-199.

Goulenok T, Seurat J, Selle AdL, Jullien V, Leflon-Guibout V, Grall N, Lescure FX, Lepeule R, Bertrand J, Fantin B, Burdet C, Lefort A
Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections.
International Journal of Antimicrobial Agents 2023, 62, 106885.

Contejean A, Maillard A, Canouï E, Kernéis S, Fantin B, Bouscary D, Parize P, Garcia-Vidal C, Charlier C
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
The Journal of Antimicrobial Chemotherapy 2023, 78, 2109-2120.

Canouï E, Rossi G, Nguyen Y, Lafont E, Rossi B, Roux O, Dokmak S, Bert F, Leflon-Guibout V, Fantin B, Lefort A
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses.
Mycoses 2023, 66, 984-991.

Chosidow S, Fantin B, Nicolas I, Mascary JB, Chau F, Bordeau V, Verdier MC, Rocheteau P, Guérin F, Cattoir V, de Lastours V
Synergistic Activity of Pep16, a Promising New Antibacterial Pseudopeptide against Multidrug-Resistant Organisms, in Combination with Colistin against Multidrug-Resistant Escherichia coli, In Vitro and in a Murine Peritonitis Model.
Antibiotics (Basel, Switzerland) 2023, 12, 81.

2022


Sokal A, Chawki S, Nguyen Y, Sauvanet A, Ponsot P, Maire F, Fantin B, de Lastours V
Specificities of acute cholangitis in patients with cancer: a retrospective comparative study of 130 episodes.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2022, 41, 143-146.

Le Bot A, Sokal A, Choquet A, Maire F, Fantin B, Sauvanet A, de Lastours V
Clinical and microbiological characteristics of reflux cholangitis following bilio-enteric anastomosis..
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2022, 41, 1139-1143.

Rossi G, Nguyen Y, Lafont E, Rossi B, Canouï E, Roux O, Dokmak S, Bert F, Fantin B, Lefort A
Large retrospective study analysing predictive factors of primary treatment failure, recurrence and death in pyogenic liver abscesses.
Infection 2022, 50, 1205-1215.

Rollin G, Rossi B, Brisse S, Decré D, Leflon-Guibout V, Bert F, Hoffmann I, Decousser JW, Fantin B, Lefort A
Spontaneous and postsurgical/traumatic Klebsiella pneumoniae meningitis: two distinct clinico-microbiological entities.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2022, 114, 185-191.

de Lastours V, El Meouche I, Chau F, Beghain J, Chevret D, Aubert-Frambourg A, Clermont O, Royer G, Bouvet O, Denamur E, Fantin B, CIPHARES Group
Evolution of fluoroquinolone-resistant Escherichia coli in the gut after ciprofloxacin treatment.
International journal of medical microbiology: IJMM 2022, 312, 151548.

2021


Chawki S, Sokal A, Duprilot M, Henry A, Leflon-Guibout V, Nicolas-Chanoine MH, Fantin B, de Lastours V
Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodes.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2021

Vanjak A, Canouï E, Honsel V, Argy N, Houzé S, Roux O, Fantin B
Early primary toxoplasmosis transmitted by liver graft: A case report.
Infectious Diseases Now 2021, 51, 315-316.

Delforge J, Sovaila S, Alix L, Didon A, Steichen O, Ranque B, Froissart A, Amadou K, Hanslik T, Cador B, Bergmann JF, Mekininan A, Goujard C, Gayet S, Cathebras P, Fantin B, Raigniac D, Weber JC, Rosenthal E, Hery L, Andres E, Benhamou Y, Bourgarit A, pour le groupe SiFMI 2015
[Characteristics of patients admitted from emergency units in 18 internal medicine departments and organisation of these departments: A cross sectional study from SNFMI (SiFMI study group) in 2015].
La Revue De Medecine Interne 2021, 42, 79-85.

Le Menestrel A, Guerin F, Chau F, Massias L, Benchetrit L, Cattoir V, Fantin B, de Lastours V
Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
The Journal of Antimicrobial Chemotherapy 2021, 77, 155-163.

2020


Canovas J, Petitjean G, Chau F, Le Monnier A, Fantin B, Lefort A
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020, 26, 1416.e5-1416.e9.

Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Fantin B, Galy A
Applicability of the CURB-65 pneumonia severity score for outpatient treatment of COVID-19.
The Journal of Infection 2020, 81, e96-e98.

Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, Doucet L, Berkani S, Oliosi E, Mallart E, Corre F, Zarrouk V, Moyer JD, Galy A, Honsel V, Fantin B, Nguyen Y
Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19.
The Journal of Infection 2020, 81, e4-e6.

Lampros A, Montardi C, Journeau L, Georgin-Lavialle S, Hanslik T, Dhôte R, Goujard C, Le Jeunne C, Mahe I, Papo T, Godeau B, Bourgarit A, Fain O, Fantin B, Dzierzynski N, Leblanc J, Nevoret C, Steichen O
[Association between psychiatric comorbidities and hospital length of stay in post-emergency internal medicine patients].
La Revue De Medecine Interne 2020, 41, 360-367.

Nguyen Y, Corre F, Honsel V, Curac S, Zarrouk V, Burtz CP, Weiss E, Moyer JD, Gauss T, Grégory J, Bert F, Trichet C, Peoc'h K, Vilgrain V, Rebours V, Fantin B, Galy A
A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area.
Annals of Medicine 2020, 52, 367-375.

Pourbaix A, Zarrouk V, Allaham W, Leflon V, Rousseau MA, Goutagny S, Guigui P, Fantin B
More complications in cervical than in non-cervical spine tuberculosis.
Infectious Diseases (London, England) 2020, 52, 170-176.

Perrineau S, Zarrouk V, Zoghlami M, Allaham W, Leflon-Guibout V, Rousseau MA, Fantin B
Different kinetics of infectious processes in vertebral osteomyelitis of pyogenic or tuberculous origin explain different timing of surgery.
Infectious Diseases (London, England) 2020, 52, 563-570.

de Lastours V, Laouénan C, Royer G, Carbonnelle E, Lepeule R, Esposito-Farèse M, Clermont O, Duval X, Fantin B, Mentré F, Decousser JW, Denamur E, Lefort A
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
The Journal of Antimicrobial Chemotherapy 2020, 75, 2334-2343.

Cheminet G, de Lastours V, Poirel L, Chau F, Peoc'h K, Massias L, Fantin B, Nordmann P
Dimercaptosuccinic acid in combination with carbapenems against isogenic strains of Escherichia coli producing or not producing a metallo-β-lactamase in vitro and in murine peritonitis.
The Journal of Antimicrobial Chemotherapy 2020, 75, 3593-3600.

Lafont E, Roux O, de Lastours V, Dokmak S, Leflon V, Fantin B, Lefort A
Pyogenic liver abscess in liver transplant recipient: A warning signal for the risk of recurrence and retransplantation.
Transplant Infectious Disease: An Official Journal of the Transplantation Society 2020, 22, e13360.

Roujansky A, de Lastours V, Guérin F, Chau F, Cheminet G, Massias L, Cattoir V, Fantin B
Analysis of Paradoxical Efficacy of Carbapenems against Carbapenemase-Producing Escherichia coli in a Murine Model of Lethal Peritonitis.
Antimicrobial Agents and Chemotherapy 2020, 64,

Cattoir V, Pourbaix A, Magnan M, Chau F, de Lastours V, Felden B, Fantin B, Guérin F
Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli..
Frontiers in microbiology 2020, 11, 575031.

Nguyen Y, Stirnemann J, Lautredoux F, Cador B, Bengherbia M, Yousfi K, Hamroun D, Astudillo L, Billette de Villemeur T, Brassier A, Camou F, Dalbies F, Dobbelaere D, Gaches F, Leguy-Seguin V, Masseau A, Pers YM, Pichard S, Serratrice C, Berger MG, Fantin B, Belmatoug N, On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee n
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
International Journal of Molecular Sciences 2020, 21,

Leo S, Lazarevic V, Girard M, Gaïa N, Schrenzel J, de Lastours V, Fantin B, Bonten M, Carmeli Y, Rondinaud E, Harbarth S, Huttner BD
Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial.
Microorganisms 2020

2019


Huttner BD, de Lastours V, Wassenberg M, Maharshak N, Mauris A, Galperine T, Zanichelli V, Kapel N, Bellanger A, Olearo F, Duval X, Armand-Lefevre L, Carmeli Y, Bonten M, Fantin B, Harbarth S, R-Gnosis WP3 study group
A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 830-838.

Fantin B, Poujade J, Grégoire N, Chau F, Roujansky A, Kieffer N, Berleur M, Couet W, Nordmann P
The inoculum effect of Escherichia coli expressing mcr-1 or not on colistin activity in a murine model of peritonitis.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 1563.e5-1563.e8.

Sokal A, Sauvanet A, Fantin B, de Lastours V
Acute cholangitis: Diagnosis and management.
Journal of Visceral Surgery 2019

Hoen B, Varon E, Debroucker T, Fantin B, Grimprel E, Wolff M, Duval X, expert and reviewing groups
Management of acute community-acquired bacterial meningitis (excluding newborns). Short text.
Medecine Et Maladies Infectieuses 2019, 49, 367-404.

Hoen B, Varon E, de Debroucker T, Fantin B, Grimprel E, Wolff M, Duval X, expert and reviewing group
Management of acute community-acquired bacterial meningitis (excluding newborns). Long version with arguments.
Medecine Et Maladies Infectieuses 2019, 49, 405-441.

Gocko X, Lenormand C, Lemogne C, Bouiller K, Gehanno JF, Rabaud C, Perrot S, Eldin C, de Broucker T, Roblot F, Toubiana J, Sellal F, Vuillemet F, Sordet C, Fantin B, Lina G, Sobas C, Jaulhac B, Figoni J, Chirouze C, Hansmann Y, Hentgen V, Caumes E, Dieudonné M, Picone O, Bodaghi B, Gangneux JP, Degeilh B, Partouche H, Saunier A, Sotto A, Raffetin A, Monsuez JJ, Michel C, Boulanger N, Cathebras P, Tattevin P, endorsed by the following scientific societies
Lyme borreliosis and other tick-borne diseases. Guidelines from the French scientific societies.
Medecine Et Maladies Infectieuses 2019, 49, 296-317.

Ruppé E, Ghozlane A, Tap J, Pons N, Alvarez AS, Maziers N, Cuesta T, Hernando-Amado S, Clares I, Martínez JL, Coque TM, Baquero F, Lanza VF, Máiz L, Goulenok T, de Lastours V, Amor N, Fantin B, Wieder I, Andremont A, van Schaik W, Rogers M, Zhang X, Willems RJL, de Brevern AG, Batto JM, Blottière HM, Léonard P, Léjard V, Letur A, Levenez F, Weiszer K, Haimet F, Doré J, Kennedy SP, Ehrlich SD
Prediction of the intestinal resistome by a three-dimensional structure-based method.
Nature Microbiology 2019, 4, 112-123.

Canouï E, Zarrouk V, Canouï-Poitrine F, Desmoulin U, Leflon V, Allaham W, de Lastours V, Guigui P, Fantin B
Surgery is safe and effective when indicated in the acute phase of hematogenous pyogenic vertebral osteomyelitis.
Infectious Diseases (London, England) 2019, 51, 268-276.

Alexandre K, Soares A, Chau F, Fantin B, Caron F, Etienne M
Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1323-1326.

Pourbaix A, Guérin F, Burdet C, Massias L, Chau F, Cattoir V, Fantin B
Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.
Antimicrobial Agents and Chemotherapy 2019, 63, e00903-19.

2018


de Lastours V, Goulenok T, Guérin F, Jacquier H, Eyma C, Chau F, Cattoir V, Fantin B
Ceftriaxone promotes the emergence of AmpC-overproducing Enterobacteriaceae in gut microbiota from hospitalized patients.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2018, 37, 417-421.

Alexandre K, Fantin B
Pharmacokinetics and Pharmacodynamics of Temocillin.
Clinical Pharmacokinetics 2018, 57, 287-296.

Froissart A, Rossi B, Ranque B, Jarrin I, Bergmann JF, Beaune S, Dautheville S, Breau N, Dauvergne A, Deluche L, Robert T, Gault N, Roy C, Zarrouk V, Steichen O, Fantin B
Effect of a Red Blood Cell Transfusion on Biological Markers Used to Determine the Cause of Anemia: A Prospective Study.
Am J Med 2018, 131, 319-322.

Kaddour K, Lemasson J, Haettich-Pialoux B, Guedj N, Belmatoug N, Treton X, Becheur H, Fantin B, Descamps V, Le Bozec P
[The value of fecal calprotectin assay in chronic panniculitis of unknown etiology].
Annales De Dermatologie Et De Venereologie 2018, 145, 702-705.

Jannic A, Maillet J, Rossi B, Guedj N, Descamps V, Fantin B, Le Bozec P
Flagellate erythema in systemic sclerosis: A case report.
JAAD case reports 2018, 4, 239-241.

Cheminet G, Kapel N, Bleibtreu A, Sadou-Yaye H, Bellanger A, Duval X, Joly F, Fantin B, de Lastours V, French Group for Fecal Microbiota Transplantation (GFTF)
Faecal microbiota transplantation with frozen capsules for relapsing Clostridium difficile infections: the first experience from 15 consecutive patients in France.
The Journal of Hospital Infection 2018, 100, 148-151.

Goulenok T, Chopin D, De Lastours V, Zarrouk V, Lepeule R, Fantin B, Lefort A
[Influenzae and pneumococcal vaccination rate in an internal medicine ward].
La Revue De Medecine Interne 2018, 39, 386-392.

Zarrouk V, Gras J, Dubée V, de Lastours V, Lopes A, Leflon V, Allaham W, Guigui P, Fantin B
Increased mortality in patients aged 75 years or over with pyogenic vertebral osteomyelitis.
Infectious Diseases (London, England) 2018, 50, 783-787.

Berleur M, Guérin F, Massias L, Chau F, Poujade J, Cattoir V, Fantin B, de Lastours V
Activity of fosfomycin alone or combined with temocillin in vitro and in a murine model of peritonitis due to KPC-3- or OXA-48-producing Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2018, 73, 3074-3080.

Miguel Montanes R, Elkrief L, Hajage D, Houssel P, Fantin B, Francoz C, Dreyfuss D, Ricard JD, Durand F
An outbreak of Pneumocytis jirovecii pneumonia among liver transplant recipients..
Transplant infectious disease : an official journal of the Transplantation Society 2018, 20, e12956.

Rossi B, Gasperini ML, Leflon-Guibout V, Gioanni A, de Lastours V, Rossi G, Dokmak S, Ronot M, Roux O, Nicolas-Chanoine MH, Fantin B, Lefort A
Hypervirulent Klebsiella pneumoniae in Cryptogenic Liver Abscesses, Paris, France.
Emerging Infectious Diseases 2018, 24, 221-229.

2017


Stahl JP, Azouvi P, Bruneel F, De Broucker T, Duval X, Fantin B, Girard N, Herrmann JL, Honnorat J, Lecuit M, Mailles A, Martinez-Almoyna L, Morand P, Piroth L, Tattevin P, reviewing group
Guidelines on the management of infectious encephalitis in adults.
Medecine Et Maladies Infectieuses 2017, 47, 179-194.

Goulenok T, Buzelé R, Duval X, Bruneel F, Stahl JP, Fantin B
Management of adult infectious encephalitis in metropolitan France.
Medecine Et Maladies Infectieuses 2017, 47, 206-220.

Perrineau S, Cazals-Hatem D, Zarrouk V, Fantin B, de Lastours V
Cytomegalovirus-associated protein-losing enteropathy in a healthy man.
Medecine Et Maladies Infectieuses 2017, 47, 562-565.

de Lastours V, Maugy E, Mathy V, Chau F, Rossi B, Guérin F, Cattoir V, Fantin B, CIPHARES Study Group
Ecological impact of ciprofloxacin on commensal enterococci in healthy volunteers.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1574-1580.

Lemaignen A, Ghout I, Dinh A, Gras G, Fantin B, Zarrouk V, Carlier R, Loret JE, Denes E, Greder A, Lescure FX, Boutoille D, Tattevin P, Issartel B, Cottier JP, Bernard L
Characteristics of and risk factors for severe neurological deficit in patients with pyogenic vertebral osteomyelitis: A case-control study..
Medicine 2017, 96, e6387.

Nguyen Y, Rossi B, Argy N, Baker C, Nickel B, Marti H, Zarrouk V, Houzé S, Fantin B, Lefort A
Autochthonous Case of Eosinophilic Meningitis Caused by Angiostrongylus cantonensis, France, 2016.
Emerging Infectious Diseases 2017, 23, 1045-1046.

2016


Buzelé R, Barbier L, Sauvanet A, Fantin B
Medical complications following splenectomy.
Journal of Visceral Surgery 2016, 153, 277-286.

de Lastours V, Fantin B
[Pyogenic brain abscesses in adults].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2016

Rossi G, Lafont E, Gasperini L, Dokmak S, Ronot M, Rossi B, Zarrouk V, Fantin B, Lefort A
[Liver abscess].
La Revue De Medecine Interne 2016, 37, 827-833.

Jayol A, Janvier F, Guillard T, Chau F, Mérens A, Robert J, Fantin B, Berçot B, Cambau E
qnrA6 genetic environment and quinolone resistance conferred on Proteus mirabilis.
The Journal of Antimicrobial Chemotherapy 2016, 71, 903-908.

Alexandre K, Chau F, Guérin F, Massias L, Lefort A, Cattoir V, Fantin B
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.
The Journal of Antimicrobial Chemotherapy 2016

Audemard-Verger A, Descloux E, Ponard D, Deroux A, Fantin B, Fieschi C, John M, Bouldouyre A, Karkowsi L, Moulis G, Auvinet H, Valla F, Lechiche C, Davido B, Martinot M, Biron C, Lucht F, Asseray N, Froissart A, Buzelé R, Perlat A, Boutboul D, Fremeaux-Bacchi V, Isnard S, Bienvenu B
Infections Revealing Complement Deficiency in Adults: A French Nationwide Study Enrolling 41 Patients.
Medicine 2016, 95, e3548.

de Lastours V, Chopin D, Jacquier H, d'Humieres C, Burdet C, Chau F, Denamur E, Fantin B
Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals.
Antimicrob Agents Chemother 2016, 60, 6941-6944.

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.
BMJ open 2016, 6, e009029.

Galy A, Lepeule R, Goulenok T, Buzele R, de Lastours V, Fantin B
Presentation and impact of catheter-associated thrombosis in patients with infected long-term central venous catheters: a prospective bicentric observational study.
Annals of Medicine 2016, 48, 182-189.

De Lastours V, Fantin B
[What future for the prescriptions of fluoroquinolones?]..
La Revue du praticien 2016, 66, 239-244.

2015


Buzelé R, Zarrouk V, Francoz C, Durand F, Fantin B
Characteristics of vertebral osteomyelitis after liver transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015

Munier AL, de Lastours V, Barbier F, Chau F, Fantin B, Ruimy R
Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment.
International Journal of Antimicrobial Agents 2015

Monnier D, Goulenok T, Allary J, Zarrouk V, Fantin B
[Starvation ketosis in a breastfeeding woman].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2015

Soubirou JF, Rossi B, Couffignal C, Ruppé E, Chau F, Massias L, Lepeule R, Mentre F, Fantin B
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1466–1472.

Rossi B, Soubirou J, Chau F, Massias L, Dion S, Lepeule R, Fantin B, Lefort A
Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.
Antimicrobial Agents and Chemotherapy 2015, 32, 1708.

de Lastours V, Fantin B
Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
Future Microbiology 2015, 10, 1241-1255.

2014


Lefort A, Chau F, Lepeule R, Dubée V, Kitzis MD, Dion S, Fantin B
Activity of fosfomycin alone or combined with cefoxitin in vitro and in vivo in a murine model of urinary tract infection due to Escherichia coli harbouring CTX-M-15-type extended-spectrum β-lactamase.
International Journal of Antimicrobial Agents 2014, 43, 366-369.

Pierre I, Zarrouk V, Noussair L, Molina JM, Fantin B
Invasive actinomycosis: surrogate marker of a poor prognosis in immunocompromised patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2014, 29, 74-79.

Lemaignen A, Goulenok T, Kalamarides S, Plat A, Pfau G, Fantin B
[Agranulocytosis and vasculitis in a cocaine addict: Levamisole, the hidden culprit].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2014, 35, 676-679.

de Lastours V, Fantin B
[Resistance to fluoroquinolones in 2013: what are the consequences in internal medicine?].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2014, 35, 601-608.

Fillion A, Koutlidis N, Froissart A, Fantin B
[Investigation and management of genito-urinary tuberculosis.].
La Revue De Medecine Interne / Fondee ... Par La Societe Nationale Francaise De Medecine Interne 2014

Roubaud Baudron C, Panhard X, Clermont O, Mentré F, Fantin B, Denamur E, Lefort A, COLIBAFI Group
Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome.
Epidemiology and Infection 2014, 142, 2672-2683.

de Lastours V, Bleibtreu A, Chau F, Burdet C, Duval X, Denamur E, Fantin B
Quinolone-resistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle.
The Journal of Antimicrobial Chemotherapy 2014, 69, 761-768.

de Lastours V, Chau F, Roy C, Larroque B, Fantin B
Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
The Journal of Antimicrobial Chemotherapy 2014

Vigan M, Stirnemann J, Caillaud C, Froissart R, Boutten A, Fantin B, Belmatoug N, Mentré F
Modeling changes in biomarkers in Gaucher disease patients receiving enzyme replacement therapy using a pathophysiological model.
Orphanet Journal of Rare Diseases 2014, 9, 95.

Desbois A, Rautou P, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M, Zarrouk V, Fantin B, Pineton de Chambrun M, Cacoub P, Valla D, Saadoun D, Plessier A
Behcet¿s disease in Budd-Chiari syndrome.
Orphanet Journal of Rare Diseases 2014, 9, 104.

Desbois AC, Rautou PE, Biard L, Belmatoug N, Wechsler B, Resche-Rigon M, Zarrouk V, Fantin B, de Chambrun MP, Cacoub P, Valla D, Saadoun D, Plessier A
Behcet's disease in Budd-Chiari syndrome..
Orphanet journal of rare diseases 2014, 9, 104.

Dubée V, Zeller V, Fantin B
[Infections associated with orthopaedic devices].
La Revue Du Praticien 2014, 64, 643-650.

2013


Goulenok T, Fantin B
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.
Clinical Pharmacokinetics 2013, 52, 869-883.

Guillard T, Cambau E, Chau F, Massias L, de Champs C, Fantin B
Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
Antimicrobial Agents and Chemotherapy 2013, 57, 5830-5835.

Cornely OA, Miller MA, Fantin B, Mullane K, Kean Y, Gorbach S
Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2013, 31, 2493-2499.

Cornely OA, Miller MA, Fantin BR, Mullane KM, Kean Y, Gorbach SL
Reply to M.R. Green et al..
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013, 31, 4379.

2012


Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31, 319-325.

Mekinian A, Stirnemann J, Belmatoug N, Heraoui D, Fantin B, Fain O, Charpentier A, Rose C
Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment.
Blood Cells, Molecules & Diseases 2012, 49, 53-57.

Lebeaux D, Zarrouk V, Petrover D, Nicolas-Chanoine MH, Fantin B
Salmonella Colindale osteomyelitis in an immunocompetent female patient.
Medecine Et Maladies Infectieuses 2012, 42, 36-37.

Froissart A, Gazaignes S, Gellen-Dautremer J, Leflon-Guibout V, Iakovlev G, Zarrouk V, Lefort A, Fantin B
[Intermittent prolonged fever triggered by efforts].
La Revue De Médecine Interne / Fondée ... Par La Société Nationale Francaise De Médecine Interne 2012, 33, 519-521.

Dubée V, Lenoir T, Leflon-Guibout V, Briere-Bellier C, Guigui P, Fantin B
Three-month antibiotic therapy for early-onset postoperative spinal implant infections.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1481-1487.

de Lastours V, Cambau E, Guillard T, Marcade G, Chau F, Fantin B
Diversity of individual dynamic patterns of emergence of resistance to quinolones in Escherichia coli from the fecal flora of healthy volunteers exposed to ciprofloxacin..
The Journal of infectious diseases 2012, 206, 1399-1406.

Lebeaux D, Larroque B, Gellen-Dautremer J, Leflon-Guibout V, Dreyer C, Bialek S, Froissart A, Hentic O, Tessier C, Ruimy R, Pelletier AL, Crestani B, Fournier M, Papo T, Barry B, Zarrouk V, Fantin B
Clinical outcome after a totally implantable venous access port-related infection in cancer patients: a prospective study and review of the literature.
Medicine 2012, 91, 309-318.

Lepeule R, Ruppé E, Le P, Massias L, Chau F, Nucci A, Lefort A, Fantin B
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
Antimicrobial Agents and Chemotherapy 2012, 56, 1376-1381.

Stirnemann J, Vigan M, Hamroun D, Heraoui D, Rossi-Semerano L, Berger MG, Rose C, Camou F, de Roux-Serratrice C, Grosbois B, Kaminsky P, Robert A, Caillaud C, Froissart R, Levade T, Masseau A, Mignot C, Sedel F, Dobbelaere D, Vanier MT, Valayanopoulos V, Fain O, Fantin B, de Villemeur TB, Mentré F, Belmatoug N
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients.
Orphanet Journal of Rare Diseases 2012, 7, 77.

2011


Stirnemann J, Boutten A, Vincent C, Mekinian A, Heraoui D, Fantin B, Fain O, Mentré F, Belmatoug N
Impact of imiglucerase on the serum glycosylated-ferritin level in Gaucher disease.
Blood Cells, Molecules & Diseases 2011, 46, 34-38.

Javaud N, Certal RDS, Stirnemann J, Morin AS, Chamouard JM, Augier A, Bouchaud O, Carpentier A, Dhote R, Dumas JL, Fantin B, Fain O
Tuberculous cerebral vasculitis: retrospective study of 10 cases..
European journal of internal medicine 2011, 22, e99-104.

Goulenok TM, Bialek S, Gaudart S, Bébéar C, Fantin B
Ureaplasma urealyticum destructive septic arthritis in a patient with systemic lupus erythematosus after rituximab therapy..
Joint bone spine 2011, 78, 323-324.

Lucet JC, Nicolas-Chanoine MH, Lefort A, Roy C, Diamantis S, Papy E, Riveros-Palacios O, Le Grand J, Rioux C, Fantin B, Ravaud P
Do case vignettes accurately reflect antibiotic prescription?.
Infection Control and Hospital Epidemiology 2011, 32, 1003-1009.

Lucet JC, Nicolas-Chanoine MH, Roy C, Riveros-Palacios O, Diamantis S, Le Grand J, Papy E, Rioux C, Fantin B, Lefort A, Ravaud P
Antibiotic use: knowledge and perceptions in two university hospitals.
The Journal of Antimicrobial Chemotherapy 2011, 66, 936-940.

Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, Mentré F, Wolff M, Denamur E, Branger C, COLIBAFI Group
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2011, 17, 557-565.

Chau F, Lefort A, Benadda S, Dubée V, Fantin B
Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains..
Antimicrobial agents and chemotherapy 2011, 55, 395-398.

Dubée V, Chau F, Arthur M, Garry L, Benadda S, Mesnage S, Lefort A, Fantin B
The in vitro contribution of autolysins to bacterial killing elicited by amoxicillin increases with inoculum size in Enterococcus faecalis..
Antimicrobial agents and chemotherapy 2011, 55, 910-912.

Lefort A, Panhard X, Clermont O, Woerther PL, Branger C, Mentré F, Fantin B, Wolff M, Denamur E, COLIBAFI Group
Host factors and portal of entry outweigh bacterial determinants to predict the severity of Escherichia coli bacteremia.
Journal of Clinical Microbiology 2011, 49, 777-783.

Michon A, Allou N, Chau F, Podglajen I, Fantin B, Cambau E
Plasmidic qnrA3 enhances Escherichia coli fitness in absence of antibiotic exposure..
PloS one 2011, 6, e24552.

2010


Fantin B
Reduced antibiotic pressure for the treatment of acute exacerbation of chronic obstructive pulmonary disease: back to the future..
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010, 51, 150-152.

de Lastours V, Chau F, Tubach F, Pasquet B, Ruppé E, Fantin B
Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission..
Antimicrobial agents and chemotherapy 2010, 54, 5193-5200.

Zarrouk V, Leflon-Guibout V, Robineaux S, Kalamarides M, Nicolas-Chanoine MH, Sterkers O, Fantin B
Broad-range 16S rRNA PCR with cerebrospinal fluid may be unreliable for management of postoperative aseptic meningitis.
Journal of Clinical Microbiology 2010, 48, 3331-3333.

Stirnemann J, Belmatoug N, Vincent C, Fain O, Fantin B, Mentré F
Bone events and evolution of biologic markers in Gaucher disease before and during treatment.
Arthritis Research & Therapy 2010, 12, R156.

2009


Fantin B, Duval X, Massias L, Alavoine L, Chau F, Retout S, Andremont A, Mentré F
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria.
The Journal of Infectious Diseases 2009, 200, 390-398.

Fantin B
Author's reply to: Vandijck et al. Enterobacteriaceae bacteremia after liver transplantation..
Transplant international : official journal of the European Society for Organ Transplantation 2009, 22, 494, author reply 495.

Bravetti AL, Mesnage S, Lefort A, Chau F, Eckert C, Garry L, Arthur M, Fantin B
Contribution of the autolysin AtlA to the bactericidal activity of amoxicillin against Enterococcus faecalis JH2-2..
Antimicrobial agents and chemotherapy 2009, 53, 1667-1669.

Muller-Serieys C, Saleh Mghir A, Massias L, Fantin B
Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus..
Antimicrobial agents and chemotherapy 2009, 53, 2145-2148.

Allou N, Cambau E, Massias L, Chau F, Fantin B
Impact of low-level resistance to fluoroquinolones due to qnrA1 and qnrS1 genes or a gyrA mutation on ciprofloxacin bactericidal activity in a murine model of Escherichia coli urinary tract infection.
Antimicrobial Agents and Chemotherapy 2009, 53, 4292-4297.

2008


Bellier C, Bert F, Durand F, Retout S, Belghiti J, Mentré F, Fantin B
Risk factors for Enterobacteriaceae bacteremia after liver transplantation.
Transplant International: Official Journal of the European Society for Organ Transplantation 2008, 21, 755-763.

Ruimy R, Dos-Santos M, Raskine L, Bert F, Masson R, Elbaz S, Bonnal C, Lucet JC, Lefort A, Fantin B, Wolff M, Hornstein M, Andremont A
Accuracy and potential usefulness of triplex real-time PCR for improving antibiotic treatment of patients with blood cultures showing clustered gram-positive cocci on direct smears..
Journal of clinical microbiology 2008, 46, 2045-2051.

Rouzet F, Dominguez Hernandez M, Hervatin F, Sarda-Mantel L, Lefort A, Duval X, Louedec L, Fantin B, Le Guludec D, Michel JB
Technetium 99m-labeled annexin V scintigraphy of platelet activation in vegetations of experimental endocarditis.
Circulation 2008, 117, 781-789.

de Lastours V, Kalamarides M, Leflon V, Rodallec M, Vilgrain V, Nicolas-Chanoine MH, Fantin B
Optimization of bacterial diagnosis yield after needle aspiration in immunocompetent adults with brain abscesses.
Neurosurgery 2008, 63, 362-367; discussion 367-368.

2007


Vanjak D, Girault G, Branger C, Rufat P, Valla DC, Fantin B
Risk factors for Clostridium difficile infection in a hepatology ward..
Infection control and hospital epidemiology 2007, 28, 202-204.

Zarrouk V, Vassor I, Bert F, Bouccara D, Kalamarides M, Bendersky N, Redondo A, Sterkers O, Fantin B
Evaluation of the management of postoperative aseptic meningitis..
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007, 44, 1555-1559.

Daurel C, Prunier AL, Chau F, Garry L, Leclercq R, Fantin B
Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus..
FEMS immunology and medical microbiology 2007, 51, 344-349.

Abgueguen P, Azoulay-Dupuis E, Noel V, Moine P, Rieux V, Fantin B, Bedos JP
Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics..
Antimicrobial agents and chemotherapy 2007, 51, 208-214.

Mohler J, Moine P, Azoulay-Dupuis E, Henin D, Fantin B
Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae..
European cytokine network 2007, 18, 23-30.

2006


Le Page L, Feydy A, Rillardon L, Dufour V, Le Hénanff A, Tubach F, Belmatoug N, Zarrouk V, Guigui P, Fantin B
Spinal tuberculosis: a longitudinal study with clinical, laboratory, and imaging outcomes..
Seminars in arthritis and rheumatism 2006, 36, 124-129.

Aslangul E, Massias L, Meulemans A, Chau F, Andremont A, Courvalin P, Fantin B, Ruimy R
Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis..
Antimicrobial agents and chemotherapy 2006, 50, 3615-3621.

de Lastours V, Papo T, Cazals-Hatem D, Eden A, Feydy A, Belmatoug N, Chauveheid MP, Lidove O, Fantin B
Bone involvement in generalized crystal-storing histiocytosis..
The Journal of rheumatology 2006, 33, 2354-2358.

2005


Bert F, Bellier C, Lassel L, Lefranc V, Durand F, Belghiti J, Mentré F, Fantin B
Risk factors for Staphylococcus aureus infection in liver transplant recipients.
Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005, 11, 1093-1099.

Labat F, Pradillon O, Garry L, Peuchmaur M, Fantin B, Denamur E
Mutator phenotype confers advantage in Escherichia coli chronic urinary tract infection pathogenesis.
FEMS immunology and medical microbiology 2005, 44, 317-321.

Dufour V, Feydy A, Rillardon L, Redondo A, Le Page L, Bert F, Belmatoug N, Fantin B
Comparative study of postoperative and spontaneous pyogenic spondylodiscitis..
Seminars in arthritis and rheumatism 2005, 34, 766-771.

Aslangul E, Ruimy R, Chau F, Garry L, Andremont A, Fantin B
Relationship between the level of acquired resistance to gentamicin and synergism with amoxicillin in Enterococcus faecalis..
Antimicrobial agents and chemotherapy 2005, 49, 4144-4148.

2004


Lefort A, Arthur M, Depardieu F, Chau F, Pouzet C, Courvalin P, Fantin B
Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
The Journal of Infectious Diseases 2004, 189, 90-97.

Buyse S, Asselah T, Vilgrain V, Paradis V, Sauvanet A, Consigny Y, Dufour V, Fantin B, Valla D, Marcellin P
Acute pulmonary embolism: a rare complication of a large non-parasitic hepatic cyst..
European journal of gastroenterology & hepatology 2004, 16, 1241-1244.

Lefort A, Pavie J, Garry L, Chau F, Fantin B
Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin..
Antimicrobial agents and chemotherapy 2004, 48, 1061-1064.

2003


Lellouche N, Belmatoug N, Bourgoin P, Logeart D, Acar C, Cohen-Solal A, Fantin B
Recurrent valvular replacement due to exacerbation of Behcet's disease by Streptococcus agalactiae infection..
European journal of internal medicine 2003, 14, 120-122.

Nazal EM, Belmatoug N, de Roquancourt A, Lefort A, Fantin B
Hypoparathyroidism preceding Riedel's thyroiditis..
European journal of internal medicine 2003, 14, 202-204.

Lefort A, Lafaurie M, Massias L, Petegnief Y, Saleh-Mghir A, Muller-Serieys C, Le Guludec D, Fantin B
Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis..
Antimicrobial agents and chemotherapy 2003, 47, 216-222.

Lefort A, Garry L, Depardieu F, Courvalin P, Fantin B
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium..
Antimicrobial agents and chemotherapy 2003, 47, 3515-3518.

Pavie J, Lefort A, Ploy MC, Massias L, Chau F, Garry L, Denis F, Fantin B
Influence of reduced susceptibility to glycopeptides on activities of vancomycin and teicoplanin against Staphylococcus aureus in experimental endocarditis..
Antimicrobial agents and chemotherapy 2003, 47, 2018-2021.

Dufour V, Fantin B
[Antibiotic prescription monitoring]..
La Revue du praticien 2003, 53, 907-916.

2002


Dauriat G, Stern JB, Similowski T, Herson S, Belmatoug N, Marceau A, Fantin B, Fournier M, Mal H
Acute respiratory failure due to diaphragmatic weakness revealing a polymyositis..
European journal of internal medicine 2002, 13, 203-205.

Malbruny B, Canu A, Bozdogan B, Fantin B, Zarrouk V, Dutka-Malen S, Feger C, Leclercq R
Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus..
Antimicrobial agents and chemotherapy 2002, 46, 2200-2207.

Pavie J, Lefort A, Zarrouk V, Chau F, Garry L, Leclercq R, Fantin B
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotics..
Antimicrobial agents and chemotherapy 2002, 46, 3061-3064.

2000


Bert F, Galdbart JO, Zarrouk V, Le Mee J, Durand F, Mentre F, Belghiti J, Lambert-Zechovsky N, Fantin B
Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients.
Clinical Infectious Diseases 2000, 31, 1295-1299.

1989


Leggett JE, Fantin B, Ebert S, Totsuka K, Vogelman B, Calame W, Mattie H, Craig WA
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
The Journal of Infectious Diseases 1989, 159, 281-292.